Clinical Trial Update: Sulindac and Epirubicin in Treating Patients With Metastatic Malignant Melanoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the combination of sulindac and epirubicin for metastatic melanoma has completed enrollment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Epirubicin (epirubicin)
• Sulindac (sulindac)

Snippet

Sponsor: Cancer Trials Ireland | Conditions: Melanoma (Skin) | Phase 2 | Status: COMPLETED